Scholarlink

<p>Systemic lupus erythematosus (SLE) is an autoimmune disease that predominantly affects women. The disease often manifests through nonspecific symptoms, such as fever, fatigue, and arthralgia; the skin and kidneys are also frequently affected. Management is guided by the treat-to-target (T2T) principle, with the goal of achieving a&#xa0;state of remission as quickly as possible. An increasing selection of medications is available for this purpose, the use of which is further detailed in the new S3 guideline on SLE and in new international recommendations. The objective of this article is to convey the central aspects concerning the pathogenesis, diagnosis, and management of SLE and to reduce uncertainties in dealing with affected patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Systemischer Lupus erythematodes – Pathogenese, klinische Präsentation, Diagnostik und Management

  • 期刊论文

  • 发表日期：

    2026年1月22日

查看全文
  • Johanna Mucke

摘要

Systemic lupus erythematosus (SLE) is an autoimmune disease that predominantly affects women. The disease often manifests through nonspecific symptoms, such as fever, fatigue, and arthralgia; the skin and kidneys are also frequently affected. Management is guided by the treat-to-target (T2T) principle, with the goal of achieving a state of remission as quickly as possible. An increasing selection of medications is available for this purpose, the use of which is further detailed in the new S3 guideline on SLE and in new international recommendations. The objective of this article is to convey the central aspects concerning the pathogenesis, diagnosis, and management of SLE and to reduce uncertainties in dealing with affected patients.